Kurma Partners is a Paris-based venture capital firm specializing in healthcare and biotechnology, investing from company creation through growth stages across Europe. The firm manages over €470 million and focuses on transforming academic scientific discoveries into biotech and medtech companies.
62% of their portfolio is in Biotech & Life Sciences. Average disclosed round size is $60.1M (across 22 rounds with reported amounts).
Portfolio
62
Fund Size
$252M
Top Stage
Series A
Last 12 Mo
9
Team
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
92 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 TargED Biopharmaceuticals B.V. | Unknown | — | Jun 2026 |
 Laigo Bio | Seed | — | Mar 2026 |
 Alveus Therapeutics Inc | Series A | $37M | Feb 2026 |
| Alveus Therapeutics Inc | Series A | $160M | Jan 2026 |
 Hopia | Unknown | — | Jan 2026 |
| TargED Biopharmaceuticals B.V. | Series A | — | Dec 2025 |
| Laigo Bio | Seed | — | Dec 2025 |
 Damae Medical | Series B | — | Nov 2025 |
 Adcytherix | Series A | — | Oct 2025 |
 Step Pharma | Series C | — | Oct 2025 |
 NUCLIDIUM AG | Unknown | $79M | Jul 2025 |
 Elkedonia | Seed | — | Jun 2025 |
 Nuevocor | Series B | $45M | May 2025 |
 Deepull | Series C | — | Apr 2025 |
| DDEEPULL DIAGNOSTICS, S.L. | Series C | — | Apr 2025 |
 Poppins | Unknown | — | Apr 2025 |
 Coave Therapeutics | Series A | $33M | Jan 2025 |
| NUCLIDIUM AG | Series B | — | Jan 2025 |
 Coave Therapeutics | Series A | $32M | Jan 2025 |
| Nuevocor | Series B | $45M | Jan 2025 |
 Spotlight Medical | Seed | — | Jul 2024 |
 Scirhom | Series A | — | Jul 2024 |
| MMemo Therapeutics AG | Series C | — | May 2024 |
 Vico Therapeutics | Series B | $60M | Jan 2024 |
| Scirhom | Unknown | — | Jan 2024 |
Page 1 of 4
Top Co-Investors
Idinvest Partners23 shared
Bpifrance18 shared
Eurazeo18 shared
Andera Partners17 shared
EQT Life Sciences14 shared
Pontifax12 shared
OrbiMed10 shared
Ysios Capital10 shared
Angelini Ventures8 shared
Idinvest8 shared
High-Tech Gründerfonds7 shared
Pureos Bioventures7 shared
UI Investissement7 shared
Fund+7 shared
Columbus Venture Partners7 shared
Sofinnova Partners7 shared
Novo Capital7 shared
Hadean Ventures6 shared
Sunstone Life Science Ventures6 shared
Last updated: 7 October 2026